The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. GeneThera's Revenue for the
three
months ended in Sep. 2022 was $0.00 Mil. GeneThera's average Accounts Receivable for the
three
months ended in Sep. 2022 was $0.00 Mil.
GeneThera Receivables Turnover Historical Data
The historical data trend for GeneThera's Receivables Turnover can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of GeneThera's Receivables Turnover
For the Biotechnology subindustry, GeneThera's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
GeneThera's Receivables Turnover Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, GeneThera's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where GeneThera's Receivables Turnover falls into.
GeneThera Receivables Turnover Calculation
Receivables Turnover measures the number of times a company collects its average accounts receivable balance.
GeneThera's Receivables Turnover for the fiscal year that ended in Dec. 2021 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
GeneThera Receivables Turnover Related Terms
Thank you for viewing the detailed overview of GeneThera's Receivables Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.
GeneThera Inc is a biotechnology company using its proprietary molecular sciences and technologies dedicated to eradicating diseases such as COVID-19, Paratuberculosis, Mad Cow Disease, Chronic Wasting Disease, and E.coli and Salmonella infections. It focuses on developing novel molecular diagnostic tests, therapeutics, and vaccines through its proprietary robotic technologies. Its Molecular Robotic/AI Platform and Therapeutic strategy (MORAPAT) is designed to prevent the spread of disease from animals and at the same time, allow better control of zoonotic infectious agents. The company has also developed a molecular system for the detection of Mycobacterium Avian Paratuberculosis in the milk of infected dairy cows.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
GTHR has been successfully added to your 